Holen Sie sich die Stockscreener-App
1.45
0.69%
0.01
Handel nachbörslich:
1.45
Schlusskurs vom Vortag:
$1.44
Offen:
$1.45
24-Stunden-Volumen:
225.33K
Relative Volume:
0.08
Marktkapitalisierung:
$60.72M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.24M
KGV:
-1.9041
EPS:
-0.7615
Netto-Cashflow:
$-4.79M
1W Leistung:
-0.68%
1M Leistung:
+5.07%
6M Leistung:
+16.00%
1J Leistung:
+31.82%
1-Tages-Spanne:
$1.45
$1.50
1-Wochen-Bereich:
$1.44
$1.53
52-Wochen-Spanne:
$0.73
$2.45
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Firmenname
Mira Pharmaceuticals Inc
Sektor
Telefon
813-369-5150
Adresse
1200 BRICKELL AVENUE, MIAMI
Vergleichen Sie MIRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.45 | 60.30M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
1,054.29 | 950.68B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
209.30 | 516.00B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
223.67 | 401.99B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
135.03 | 259.40B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
98.27 | 248.85B | 63.90B | 19.05B | 13.05B | 7.5596 |
Mira Pharmaceuticals Inc Aktie (MIRA) Neueste Nachrichten
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog - Daytona Beach News-Journal
MIRA Pharmaceuticals expands stock offering by $15M - MSN
Mira Pharmaceuticals increases at-the-market offering by $15.2 million - Investing.com Canada
MIRA Pharmaceuticals Inc. (MIRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
MIRA Pharmaceuticals Expands Stock Offering by $15M - TipRanks
MIRA Pharmaceuticals Increases Stock Offering Limit - TradingView — Track All Markets
Mira Pharmaceuticals (MIRA) Stock Analysis Report | Financials & Insights - Benzinga
How MIRA Pharmaceuticals Inc. stock performs in rising dollar environmentTrade Ideas & Verified Technical Signals - Newser
Why MIRA Pharmaceuticals Inc. stock is seen as undervaluedJuly 2025 Review & Daily Technical Forecast Reports - Newser
Is MIRA Pharmaceuticals Inc. stock attractive for passive investorsTrade Volume Summary & Fast Exit and Entry Trade Guides - Newser
Why MIRA Pharmaceuticals Inc. stock remains on watchlistsAnalyst Upgrade & Scalable Portfolio Growth Methods - Newser
MIRA Pharmaceuticals (NASDAQ:MIRA) and Annovis Bio (NYSE:ANVS) Critical Analysis - Defense World
Telomir and Mira Pharmaceuticals advance through key development milestones with Recipharm support - marketscreener.com
MIRA Pharmaceuticals (NASDAQ:MIRA) Rating Lowered to Sell at Wall Street Zen - MarketBeat
What risks investors should watch in MIRA Pharmaceuticals Inc. stockQuarterly Earnings Report & Real-Time Volume Analysis - newser.com
Will MIRA Pharmaceuticals Inc. stock see PE expansionProfit Target & Trade Opportunity Analysis - newser.com
What high frequency data says about MIRA Pharmaceuticals Inc.Weekly Market Outlook & Fast Exit and Entry Trade Guides - newser.com
Why MIRA Pharmaceuticals Inc. stock is favored by pension funds2025 Historical Comparison & Fast Gain Stock Trading Tips - newser.com
Is MIRA Pharmaceuticals Inc. stock trading near support levelsJuly 2025 Catalysts & Verified Momentum Stock Ideas - newser.com
Will MIRA Pharmaceuticals Inc. stock maintain growth storyJuly 2025 Momentum & Fast Entry High Yield Stock Tips - newser.com
Is MIRA Pharmaceuticals Inc. showing signs of accumulationMarket Growth Report & Long-Term Capital Growth Ideas - newser.com
Will MIRA Pharmaceuticals Inc. continue its uptrendDip Buying & Smart Allocation Stock Reports - newser.com
Should you wait for a breakout in MIRA Pharmaceuticals Inc.July 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Will MIRA Pharmaceuticals Inc. stock benefit from sector rotation2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - newser.com
Applying big data sentiment scoring on MIRA Pharmaceuticals Inc.Earnings Miss & Long-Term Growth Stock Strategies - newser.com
What earnings revisions data tells us about MIRA Pharmaceuticals Inc.2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
Using R and stats models for MIRA Pharmaceuticals Inc. forecasting2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
Is MIRA Pharmaceuticals Inc. forming a bottoming baseLong Setup & Fast Entry and Exit Trade Plans - newser.com
Finanzdaten der Mira Pharmaceuticals Inc-Aktie (MIRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
0.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):